Official Title
Efficacy of Inhaled Nitroglycerin in Moderate to Severe Cases of COVID-19 Patients
Brief Summary

In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization

Status
Completed
Conditions
Corona Virus Infection
Interventions

Drug: Nitroglycerin

2 mg/ml solution of nitroglycerin used for nebulization four hourly

Eligibility Criteria

Inclusion Criteria:

Diagnosed admitted cases of Covid-19 degree of illness should be moderate to severe both
male and female every age group

Exclusion Criteria:

allergic to nitroglycerin sudden drop in blood pressure not given consent

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Pakistan
Locations

Bahria Town International Hospital
Lahore, Punjab, Pakistan

Sponsors / Collaborators
University of Lahore
NCT Number
NCT04686760
MeSH Terms
Coronavirus Infections
Nitroglycerin